Drug-Drug Interaction Study of VCH-222 and Telaprevir in Healthy Subjects
Clinical trial NCT00958152 · COMPLETED
Trial details
- NCT number
- NCT00958152
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2010-01-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.